Business ❯ Finance ❯ Market Analysis ❯ Stock Ratings

Investment Recommendations

ASML Reinforces Monopoly as Analysts Lift Targets and Board Clears €12 Billion Buyback

Strong margins, recurring service revenue, a multi‑year backlog underpin analyst forecasts for AI-driven demand despite export limits to China.

Stories older than 24h

FDA Setback Puts uniQure’s Huntington’s Gene Therapy Filing in Doubt